Skip to main content
. 2020 Feb 17;10(2):e032868. doi: 10.1136/bmjopen-2019-032868

Figure 1.

Figure 1

Study design and flow of participants. IC, informed consent; OLP, open-label placebo; PMS, premenstrual syndrome; TAU, treatment as usual.